Purpose: this study investigated the in vivo antitumor effects of electroch
emotherapy (ECT) using electroporation and bleomycin in a hamster tongue ca
ncer model to assess its clinical applicability.
Materials and Methods: Twenty animals with chemically induced tongue cancer
were divided into four experimental groups designated B-E-, B-E+, B+E-, an
d B+E+. The B+E+ and B+E- groups received an intraperitoneal injection of 1
00 mu g bleomycin. Fifteen minutes after the injection, the B+E+ animals re
ceived electric pulses. The B-Ef group received only electric pulses. The B
-E- group received neither bleomycin nor electric pulses. Each group receiv
ed the same treatment twice. The antitumor effects were assessed based on t
umor volume reduction and histologic findings.
Results: The B+E+ group showed remarkable tumor volume reduction, decreasin
g an average to 8.8% of its original volume 14 days after the treatment. Co
mplete loss of the protruding tumor was observed in two of the five animals
. Histologically, the tumors of the B+E+ group consisted of severely degene
rated tumor cells and desquamative keratinizing cells. No living cancer cel
ls were detected in three animals. The B+E-, B-E+, and B-E- groups showed p
rogressive tumor growth, exceeding 200% of initial tumor volume during the
experimental period.
Conclusion: The current study showed remarkable antitumor effects of ECT wi
th bleomycin in the hamster tongue cancer model. ECT with bleomycin may be
clinically applicable to the treatment of oral cancer.